People with cataracts now have options. A cataract is a clouding that occurs in the normal lens that comes as part of the normal aging process. The cure is a sophisticated procedure called lens replacement which is performed rapidly and with virtually no pain or discomfort. What is so exciting today is that lens replacement surgery or cataract surgery now has the option of being a refractive procedure as well. In other words, if you have a cataract and are wearing glasses, you can have lens replacement surgery and no longer need glasses. The improvements are so significant that we can now replace lenses with a new lens that can correct both near and distance vision. Because we, at The Eye Clinic of Texas have so much experience with refractive procedures, LASIK, and excimer laser refractive procedures, we have been performing refractive lens implantation for years

The Eye Clinic of Texas is hosting a series of contests to win FREE LASIK.  All you have to do is take our quick, 10 question test.  [intlink id="1857" type="page" /]

One of the most frequent questions patients ask is whether or not the LASIK procedure will last. The simple answer is yes, it does last. We have a long experience with laser refractive surgery – 20 years to be exact, and for most of our patients, laser refractive surgery lasts. We have patients who had the procedure 20 years ago and have had little or no change in their refractive error. Of course, as patients develop changes in their own bodies, they may develop refractive changes as well. Diabetes and cataracts can change the refraction of an eye and thus the need for an enhancement.

LASIK lasts as long as it is performed within the range in which it is considered effective. If we expand the parameters beyond of treatment beyond certain limits, the refraction can change with time. Because we have such a long experience with the procedure, we do know what the limits are.

RESEARCH STUDY

The Eye Clinic of Texas is conducting a research study for people with dry eye disease.  The purpose of this research study is to develop a better understanding of the natural history of dry eye disease.

To be eligible for this research study, you must

  • Be at least 55 years old if male or, if female, at least 40 years old with perimenopausal symptoms (or post menopausal)
  • Have dry eye disease
  • Have moderate to severe eye surface discomfort and symptoms of unhealthy tears
  • Be willing to attend 6 study visits over a period of 24 months
  • NOT have a history of herpes keratitis, varizella zoster, or allergic conjunctivitis
  • NOT use or plan to use topical glaucoma medications during the course of the study
  • NOT have had cataract surgery, LASIK, LASEK, or PRK procedure within the past 12 months

We are also studying people who do not have dry eye disease.  To be eligible to participate in this portion of the study, you must

  • Be at least 55 years old if male or, if female, at least 40 years old with perimenopausal symptoms (or post menopausal)
  • Be willing to attend 6 study visits over a period of 24 months
  • NOT have symptoms of dry eye disease
  • NOT have a history of herpes keratitis, varizella zoster, or allergic conjunctivitis
  • NOT use or plan to use topical glaucoma medications during the course of the study
  • NOT have had cataract surgery, LASIK, LASEK, or PRK procedure within the past 12 months

 If you are eligible for this study, you will receive eye exams at no cost to you and you may receive compensation for your time.   There may be reasons why you would not be eligible to participate, and we will discuss this with you.   If you are interested in learning more about this research study, please contact a member of our office staff.

The Failure of the Shuttle to Return Home

There is no place that is or was more committed to the space program of the United States or to the Orbital Shuttle and the space station than the Johnson Space Center in Houston, Texas. John Kennedy traveled to Houston to announce to the world that the United States would put a man on the moon. When that man landed on the moon, his message was directed to Houston. In fact, all significant messages from space were addressed to Houston. It is unconscionable that Houston should not be given a shuttle to memorialize the commitment that this community and its people have made to the space program of our country.

The Merger of Alcon and Novartis has been Completed 

Alcon and Novartis have announced the completion of their merger. This is a very significant event in the ophthalmic world.  Alcon was already a leader is providing pharmaceuticals, lasers, and intraocular lenses. As Kevin Buehler, head of Alcon stated, “Through this merger, Alcon now truly serves the full lifecycle of patient needs across acute and chronic eye diseases, ophthalmic conditions treated with surgical procedures, and multiple options to address the correction of refractive error.” 

We have had a longstanding relationship with Alcon. Our excimer lasers are all manufactured and maintained by Alcon and much of the surgical equipment that we use at the surgery centers are manufactured by Alcon. In addition, we use Alcon intraocular lenses. Because of this, we are really excited about the merger and know that Novartis will be able to support expanded research and development which will inevitably result in new products that will help our patients.

 This is an exciting event for ophthalmology and our patients and we look forward to our future